Mallinckrodt

Mallinckrodt — Acquisitions

Every M&A deal made by Mallinckrodt, sorted by date.

Total deals 12 Total value $14.8B View company profile →
12
Total deals
$14.8B
Total value
$1.8B
Avg deal
$6.7B
Largest
Acquisition activity by year
Deals announced per year
97 12 14 15 16 17 25
# Acquired Date Type Status Price
1
Endo Pharmaceuticals
Endo develops and markets generics and branded medications for patient care.
2025-03-13 Merge Complete $6.7B Deal →
2
Sucampo Pharmaceuticals
Sucampo is a biopharmaceutical company.
2017-12-26 Acquisition Complete $1.2B Deal →
3
Ocera Therapeutics
Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics …
2017-11-02 Acquisition Complete $42.0M Deal →
4
InfaCare Pharmaceutical
InfaCare Pharmaceutical is a pharmaceutical company that develops pharmaceutical…
2017-08-04 Acquisition Complete Deal →
5
Hemostasis
Hemostasis is a manufacturer of medical devices.
2016-12-18 Acquisition Complete Deal →
6
Stratatech
Stratatech develops cell-based and tissue-engineered skin substitute products fo…
2016-08-10 Acquisition Complete Deal →
7
Therakos
Therakos provides extracorporeal photopheresis immune modulation therapy to enha…
2015-08-10 Acquisition Complete $1.3B Deal →
8
Ikaria
Ikaria is a critical care firm that develop innovative therapeutics and interven…
2015-03-05 Acquisition Complete $2.3B Deal →
9
Questcor Pharmaceuticals
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the tre…
2014-04-07 Acquisition Complete Deal →
10
Cadence Pharmaceuticals
Cadence Pharmaceuticals is a manufactures of medicines , especially pain managem…
2014-02-11 Complete $1.3B Deal →
11
CNS Therapeutics
CNS Therapeutics develops pharmaceuticals for the treatment of neurological diso…
2012-09-24 Acquisition Complete $100.0M Deal →
12
N
Nellcor Puritan Bennett
Nellcor Puritan Bennett manufactures patient monitoring instruments and disposab…
1997-07-24 Acquisition Complete $1.8B Deal →